Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors November 8:00 ...
Background Adverse childhood experiences (ACEs) are linked to poor health and social outcomes, with growing interest in their ...
The treatment landscape for systemic lupus erythematosus (SLE) has shifted greatly in recent years, driven by the emergence ...
This last week the FDA removed the black box warning label on hormone replacement therapy for menopause. When I heard this, I ...
Trained immunity is reshaping our understanding of host defense by demonstrating that innate immune cells once thought to lack memory can be reprogrammed to mount heightened responses to subsequent ...
Background With the acceleration of globalisation and the increasing frequency of international exchanges, the risk of ...
A tailored approach with rapid needs assessment before and during implementation to address local testing site barriers in ...
Background Postoperative ileus (POI) is a common complication after abdominal surgery that significantly delays recovery. Evidence suggests that the general anaesthetic propofol inhibits ...
Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback